* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos FCF Margin % Chart
BSP:PNVL3 vs LLY, JNJ, ABBV: FCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dimed Distribuidora de Medicamentos FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dimed Distribuidora de Medicamentos's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a FCF Margin % of 3.51% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dimed Distribuidora de Medicamentos and its competitors. This is 88% above median its historical median of 1.87. According to the industry distribution chart, Dimed Distribuidora de Medicamentos ranks #404 out of 958 companies in the Drug Manufacturers industry, placing it in the top 42.2%.
Is Dimed Distribuidora de Medicamentos' FCF Margin % too high?
Dimed Distribuidora de Medicamentos' current FCF Margin % of 3.51% is 88% above median its 10-year median of 1.87. The Drug Manufacturers industry median FCF Margin % is 2.45. Dimed Distribuidora de Medicamentos' value of 3.51% is 43.6% above this industry median. Based on the distribution chart, Dimed Distribuidora de Medicamentos ranks #404 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dimed Distribuidora de Medicamentos ranks #404 out of 958 companies for FCF Margin %. This puts Dimed Distribuidora de Medicamentos in the upper half of its industry. The industry median FCF Margin % is 2.45. Dimed Distribuidora de Medicamentos' value of 3.51% is 43.6% above this benchmark. While the company's 10-year median is 1.87 vs. the industry median of 2.45, Dimed Distribuidora de Medicamentos has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dimed Distribuidora de Medicamentos's current FCF Margin % of 3.51% is 43.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dimed Distribuidora de Medicamentos and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dimed Distribuidora de Medicamentos's current FCF Margin % is 3.51%, which is 88% above median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.48, compared to a current price of R$11.34 — trading 15.9% below its estimated fair value. The current FCF Margin % is 3.51%, which is 88% above median its 10-year median of 1.87 and 43.6% above the Drug Manufacturers industry median of 2.45. Dimed Distribuidora de Medicamentos' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current FCF Margin % is 3.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued.
The current stock price of R$11.34 is trading 15.9% below its estimated GF Value™ of R$13.48.
GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.
Key valuation signals for BSP:PNVL3:
FCF Margin %: 3.51% (88% above median its 10-year median of 1.87)
GF Value™: R$13.48 vs. price of R$11.34 (15.9% below fair value)
Industry Position: 43.6% above the Drug Manufacturers median (#404 of 958)
No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dimed Distribuidora de Medicamentos Business Description
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
88GF Score
Get the complete analysis for BSP:PNVL3
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PNVL3 has been successfully added to your 
